🇺🇸 FDA
Pipeline program

Colesevelam hydrochloride-MMX® modified-release placebo tablets, Colesevelam hydrochloride-MMX® 900 mg modified-release tablets

CB-01-33/01

Phase 2 small_molecule active

Quick answer

Colesevelam hydrochloride-MMX® modified-release placebo tablets, Colesevelam hydrochloride-MMX® 900 mg modified-release tablets for bile acid diarrhoea (BAD) is a Phase 2 program (small_molecule) at Cosmo Technologies Ltd with 1 ClinicalTrials.gov record(s).

Program details

Company
Cosmo Technologies Ltd
Indication
bile acid diarrhoea (BAD)
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials